CP 55,244
From Wikipedia, the free encyclopedia
|
CP 55,244
|
|
| Systematic (IUPAC) name | |
| (2S,4S,4aS,6R,8aR)-6-(hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-ol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C26H42O3 |
| Mol. mass | 402.608 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
CP 55,244 is a drug which is a cannabinoid receptor agonist. It has analgesic effects and is used in scientific research. It is a potent CB1 full agonist with a Ki of 0.21nM, making it more potent than the commonly used full agonist HU-210.[1]
[edit] References
- ^ Griffin G, Wray EJ, Martin BR, Abood ME. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British Journal of Pharmacology. 1999 Oct;128(3):684-8. PMID 10516649
|
|||||||||||||||||||||||||||||||||||||

